Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system agents. Its structure supports the creation of bioactive molecules with potential antipsychotic or antidepressant activity. Commonly employed in research settings for designing novel piperazine-based therapeutics due to its ability to interact with neurotransmitter receptors. Also utilized in the preparation of selective receptor ligands for neurological studies.